The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December ...
ACIP is set to meet on March 18 and 19 to discuss COVID vaccine injuries and long COVID, according to the meeting agenda. They are likely to recommend further changes to the childhood immunization ...
Christine Dunham is a leading expert on the ribosome—an elaborate macro-molecular machine that operates like a factory within a cell to manufacture proteins. "The ribosome is really the most ...
HHS calls MIT professor ‘more than qualified’ for advisory panel and calls ‘attacks’ on him ‘politically motivated’ ...
A team from University of Toronto Engineering is the first to synthesize long noncoding RNA (lncRNA) outside the cell — a new approach to drug ...
Researchers create the first sex-specific GLP-1 brain atlas, revealing why weight-loss drugs work differently in men and women.
Reviewing the role, regulatory mechanisms and therapeutic potential of METTL16 in cancer Cancer remains a leading cause of mortality, with its onset ...
BioNTech’s CEO and his fellow co-founder will depart the biopharma by the end of the year to head up a new company focused on “next generation mRNA innovations.” Uğur Şahin, M.D., who is currently the ...
Discover how scientists are revolutionizing colorectal cancer treatment by targeting a key protein linked to tumor growth and blood vessel formation.
Since the COVID-19 pandemic, mRNA vaccines have gained attention as a next-generation pharmaceutical technology. mRNA therapeutics work by delivering ...
Discover the molecular mechanisms behind severe blood clots linked to specific COVID-19 vaccines, revealing crucial insights for future vaccine safety.
Deep-UV resonance Raman (DUVRR) spectroscopy with excitation at 266 nanometers, matching the maximum UV absorption of mRNA, enables spectral differentiation of mRNA based on its degree of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results